← Back to Analyst Consensus 
RLAY Buy
Relay Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 19
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 11, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 20, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Aug 14, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Aug 10, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 47% |
| Aug 7, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Jul 21, 2026 | Goldman Sachs | maintain | Buy → Buy | — | 54% |
| Jul 16, 2026 | Canaccord Genuity | initiate | — → Buy | — | 48% |
| Jul 8, 2026 | JP Morgan | initiate | — → Overweight | — | 54% |
| May 26, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| May 26, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| May 20, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| May 20, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 47% |
| May 19, 2026 | Raymond James | maintain | Strong Buy → Strong Buy | — | 54% |
| Apr 29, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Apr 28, 2026 | Goldman Sachs | maintain | Buy → Buy | — | 54% |
| Apr 28, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 47% |
| Apr 28, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Apr 28, 2026 | Oppenheimer | maintain | Outperform → Outperform | — | 52% |
| Apr 14, 2026 | Jones Trading | initiate | — → Hold | — | 50% |
| Apr 8, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Mar 23, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Mar 17, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 47% |
| Mar 17, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Mar 13, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Feb 27, 2026 | Wells Fargo | maintain | Overweight → Overweight | $15 | 54% |
| Jan 26, 2026 | Oppenheimer | upgrade | Perform → Outperform | $14 | 52% |
| Dec 12, 2025 | Wells Fargo | upgrade | Equal-Weight → Overweight | $13 | 54% |
| Nov 7, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $6 | 54% |
| Aug 26, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $14 | 44% |
| Aug 8, 2025 | Raymond James | maintain | Strong Buy → Strong Buy | $19 | 54% |
| May 7, 2025 | Guggenheim | maintain | Buy → Buy | $10 | 52% |
| Apr 17, 2025 | Wells Fargo | initiate | — → Equal-Weight | $4 | 54% |
| Mar 7, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Feb 27, 2025 | Goldman Sachs | maintain | Buy → Buy | $18 | 54% |
| Feb 27, 2025 | Stifel | maintain | Buy → Buy | $23 | 53% |
| Jan 14, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Dec 12, 2024 | JMP Securities | reiterate | Market Outperform → Market Outperform | $21 | 53% |
| Dec 5, 2024 | Leerink Partners | maintain | Outperform → Outperform | $18 | 51% |
| Dec 4, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $16 | 44% |
| Dec 4, 2024 | Leerink Partners | maintain | Outperform → Outperform | $18 | 51% |
| Nov 8, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $20 | 44% |
| Oct 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $19 | 44% |
| Sep 17, 2024 | JMP Securities | reiterate | Market Outperform → Market Outperform | $21 | 53% |
| Sep 16, 2024 | Stifel | reiterate | Buy → Buy | $28 | 53% |
| Sep 16, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $19 | 44% |
| Sep 10, 2024 | B of A Securities | maintain | Buy → Buy | $24 | 53% |
| Sep 10, 2024 | JP Morgan | maintain | Overweight → Overweight | $21 | 54% |
| Sep 10, 2024 | Barclays | maintain | Overweight → Overweight | $17 | 53% |
| Sep 10, 2024 | Jefferies | upgrade | Hold → Buy | $16 | 52% |
| Sep 10, 2024 | Oppenheimer | downgrade | Outperform → Perform | $0 | 52% |
| Aug 7, 2024 | JP Morgan | maintain | Overweight → Overweight | $23 | 54% |
Price Target Trend
May 21, 2026 Latest: $27.58 Oct 25, 2026
EPS Estimates
+1q $-0.38
Lo: $-0.46 Hi: $-0.29
11 analysts +1y $-1.63
Lo: $-1.83 Hi: $-1.11
11 analysts 0y $-1.61
Lo: $-1.72 Hi: $-1.47
11 analysts 0q $-0.40
Lo: $-0.43 Hi: $-0.36
11 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days